ClinicalTrials.Veeva

Menu

Role of Skin Cleansing and Prophylactic Antibiotic in Preventing Infectious Morbidity After Cesarean Section Delivery

R

Raghda Gamal Mohamed

Status

Unknown

Conditions

Postpartum Infectious Morbidity in Cesarean Section Delivery

Treatments

Procedure: Women undergo cesarean section delivery

Study type

Observational

Funder types

Other

Identifiers

NCT03007706
MiniaMUH

Details and patient eligibility

About

This study aims to determine the effectiveness of skin cleansing and prophylactic antibiotics given to women undergoing a cesarean section for reducing the incidence of postpartum infectious morbidity and to assess potential maternal adverse effects and any impact on the infant.

Enrollment

200 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Women undergoing cesarean delivery, both elective and non-elective.
  2. Rupture of membranes and labor contractions will be allowed.

Exclusion criteria

  1. Unknown outcome from the patient.
  2. Refusing to participate in the study from the admission conse
  3. Allergy to antibiotics.
  4. Any visible infection.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems